Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesley Liu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Chembiochem : a European Journal of Chemical Biology|July 9, 2004
Structure-based enhancement of the first anomeric glucokinaseJie Yang, Lesley Liu, Jon S Thorson
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2003
Creation of the first anomeric D/L-sugar kinase by means of directed evolutionDirk Hoffmeister, Jie Yang, Lesley Liu, et al.
Chemistry & Biology|June 25, 2005
Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomizationJie Yang, Xun Fu, Jianchun Liao, et al.
Bioorganic & Medicinal Chemistry|April 29, 2004
Natural product glycorandomizationJie Yang, Dirk Hoffmeister, Lesley Liu, et al.
Molecular Pharmacology|January 8, 2017
Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor SignalingAndrew T Bender, Anna Gardberg, Albertina Pereira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2018
Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of BtkRichard Caldwell, Lesley Liu-Bujalski, Hui Qiu, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2018
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hitHui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, et al.
Chemmedchem|December 7, 2018
Discovery of Affinity-Based Probes for Btk Occupancy AssaysHui Qiu, Richard Caldwell, Lesley Liu-Bujalski, et al.
Clinical Immunology (Orlando, Fla.)|January 29, 2016
Btk inhibition treats TLR7/IFN driven murine lupusAndrew T Bender, Albertina Pereira, Kai Fu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|July 9, 2004
Structure-based enhancement of the first anomeric glucokinaseJie Yang, Lesley Liu, Jon S Thorson
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2003
Creation of the first anomeric D/L-sugar kinase by means of directed evolutionDirk Hoffmeister, Jie Yang, Lesley Liu, et al.
Chemistry & Biology|June 25, 2005
Structure-based engineering of E. coli galactokinase as a first step toward in vivo glycorandomizationJie Yang, Xun Fu, Jianchun Liao, et al.
Bioorganic & Medicinal Chemistry|April 29, 2004
Natural product glycorandomizationJie Yang, Dirk Hoffmeister, Lesley Liu, et al.
Molecular Pharmacology|January 8, 2017
Ability of Bruton's Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor SignalingAndrew T Bender, Anna Gardberg, Albertina Pereira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2019
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease ModelsPhilipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2018
Discovery of a novel series of pyridine and pyrimidine carboxamides as potent and selective covalent inhibitors of BtkRichard Caldwell, Lesley Liu-Bujalski, Hui Qiu, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2018
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hitHui Qiu, Lesley Liu-Bujalski, Richard D Caldwell, et al.
Chemmedchem|December 7, 2018
Discovery of Affinity-Based Probes for Btk Occupancy AssaysHui Qiu, Richard Caldwell, Lesley Liu-Bujalski, et al.
Clinical Immunology (Orlando, Fla.)|January 29, 2016
Btk inhibition treats TLR7/IFN driven murine lupusAndrew T Bender, Albertina Pereira, Kai Fu, et al.
Pageof 2